Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory diseases. The guideline was developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). The guideline is endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG).

Get The CPG